Dr. Lorne Tyrrell Edmonton, AB Award Type: Encana Principal Award Category: Medical Science Year: 2005

Award sponsored by

Innovation:
Discovered a unique system to identify compounds with antiviral activity. The drug lamivudine was then shown by Dr. Tyrrell to be a very potent treatment of chronic hepatitis B virus (HBV) infection and was the first oral antiviral agent licensed to treat this global disease.

Read the News Release and Media Backgrounder for additional information